Skip to content
2000
Volume 1, Issue 1
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Brain tumors can be highly aggressive and debilitating for many patients and lead to an untimely death in just a few months. Unfortunately, due to the location of many brain tumors, therapy with ionizing radiation, chemotherapeutic agents and/or surgery has limited rewards. In addition, the probability of totally removing highly infiltrative tumors, particularly gliomas, is extremely low and rarely provides a cure. The need for directed targeting and ablation of tumors with minimal damage to nearby healthy tissue has lead to the most recent findings and uses of neural stem cells for therapeutic treatment of brain tumors. Recently, some very promising studies have demonstrated that exogenous neural stem cells have the remarkable ability to migrate very long distances towards sites of metastasis after transplantation. These studies also show that intravascular injections of neural stem cells may lead to preferential migration towards central nervous system tumors. It has also been demonstrated that genetically modified neural stem cells, engineered to produce antitumor molecules, upon transplantation, have the ability to migrate towards tumors and reduce tumor mass directly or through a “bystander” effect. Here we review the current literature examining the promise of utilizing genetically modified neural stem cells as vehicles for CNS tumor therapy.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/157488806775269070
2006-01-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/157488806775269070
Loading

  • Article Type:
    Research Article
Keyword(s): brain tumors; gliomas; Neural stem cells; review; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test